Prime Medicine Inc. (PRME) Social Stream

Prime Medicine Inc. (PRME): $20.00

2.35 (+13.31%)

POWR Rating

Component Grades













Add PRME to Watchlist
Sign Up

Industry: Biotech


of 401

in industry

PRIME MEDICINE INC (PRME) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PRME.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-11-15 4 $27 $22 $24.25 $17.58 37.94%
2023-01-24 4 $27 $21 $23.75 $17.58 35.1%
NA 4 $NA $NA $NA $17.58 NA%

PRME Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, PRIME MEDICINE INC's number of analysts covering the stock is higher than 47.94% of them.
  • PRIME MEDICINE INC's variance in analysts' estimates is lower than 74.42% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, PRIME MEDICINE INC's upside potential (average analyst target price relative to current price) is greater than 51.1% of them.
  • In terms of how PRIME MEDICINE INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 122.3% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PRIME MEDICINE INC are CDXC, MTEX, and MNMD.

What is the outlook for PRME? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5888 seconds.